On March 3, 2020 Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of agents designed to activate immune response to cancers, reported it will release its fourth quarter and full year 2019 financial results before the market opens on Thursday, March 12, 2020 (Press release, Agenus, MAR 3, 2020, View Source [SID1234555107]). Agenus executives will host a conference call and webcast at 8:30 a.m. ET the same day.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Conference Call and Webcast Information:
Date: Thursday, March 12, 2020
Time: 8:30 a.m. ET
Domestic Dial-in Number: 1-844-492-3727 (U.S.)
International Dial-in Number: 1-412-317-5118 (International)
Conference ID: Agenus
The call will also be webcast and will be accessible from the Company’s website at View Source or via the link: View Source
A replay will be available on the Company’s website approximately two hours after the call.